Please login to the form below

The Specials Laboratory

The Specials lab manufactures and supplies Specials drug tariff and non-tariffed unlicensed medicines (commonly known as 'specials') to community Pharmacists, Doctors, Vet Surgeons and Hospitals - within 24 hours. We provide hospitals with a space and time saving over labelling service, which involves the bespoke design and labelling of medicines. Once set-up, we store your over labelled products and deliver what you want, when you want - again, within 24 hours. And for hospitals, we also offer investigational medicinal product (IMP) manufacturing from our MHRA-licensed sites so we can meet the supply needs of hospital-based clinical trials.

This is a FREE listing




Below are full profiles from other companies in this area

Company Details

The Specials Laboratory

Telephone:01661 831 811

Contact

Address:
Unit 1 Regents Drive Low Prudhoe Industrial Estate
Prudhoe
Northumberland
NE42 6PX
United Kingdom

Latest content from PMHub

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape look like?
Research Partnership
Onyx Health Announces Two Top Appointments
Onyx health have made two senior appointments to their communications team ahair@onyxhealth.com
As HCPs Increasingly Expect Personalized Engagement, Pharmas Turn to Modular Intelligent Content. How Does This Work?
While personalized omnichannel communication is becoming the only truly acceptable option in brand communications, Life Sciences are deeply affected by the change. Compared to retail, the amounts of information to deliver alongside the key message are predictably greater for a pharmaceutical product. Even without taking into consideration the “new” channels like social, messengers, etc. that are explored by pharmaceutical marketers, the amounts of content to be produced are growing. To cope with the challenge, pharmaceutical companies are looking to optimize content production and management. Several approaches are used, from establishing centralized Content Factories (hubs) to completely rethinking content as such. Modular Content (and its derivative, Smart Content) are the most promising strategy. What can already be said about it? Viseven
Lucid Group: Orange the World
Lucid Group Communications Limited